Skip to main content

Table 1 Peptide candidates for personalized peptide vaccination

From: A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time

Symbol for peptide Origin protein Position of peptide Amino acid sequence HLA type
CypB-129 Cyclophilin B 129-138 V A2,A3supa
Lck-246 p56 lck 246-254 KLVERLGAA A2
Lck-422 p56 lck 422-430 DVWSFGILL A2,A3sup
MAP-432 ppMAPkkk 432-440 DLLSHAFFA A2,A26
WHSC2-103 WHSC2 103-111 ASLDSDPWV A2,A3supa,A26
HNRPL-501 HNRPL 501-510 NVLHFFNAPL A2,A26
UBE-43 UBE2V 43-51 RLQEWCSVI A2
UBE-85 UBE2V 85-93 LIADFLSGL A2
WHSC2-141 WHSC2 141-149 ILGELREKV A2
HNRPL-140 HNRPL 140-148 ALVEFEDVL A2
SART3-302 SART3 302-317 LLQAEAPRL A2
SART3-309 SART3 309-317 RLAEYQAYI A2
SART2-93 SART2 93-101 DYSARWNEI A24
SART3-109 SART3 109-118 VYDYNCHVDL A24,A3supa,A26
Lck-208 p56 lck 208-216 HYTNASDGL A24
PAP-213 PAP 213-221 LYCESVHNF A24
PSA-248 PSA 248-257 HYRKWIKDTI A24
EGFR-800 EGF-R 800-809 DYVREHKDNI A24
MRP3-503 MRP3 503-511 LYAWEPSFL A24
MRP3-1293 MRP3 1293-1302 NYSVRYRPGL A24
SART2-161 SART2 161-169 AYDFLYNYL A24
Lck-486 p56 lck 486-494 TFDYLRSVL A24
Lck-488 p56 lck 488-497 DYLRSVLEDF A24
PSMA-624 PSMA 624-632 TYSVSFDSL A24
EZH2-735 EZH2 735-743 KYVGIEREM A24
PTHrP-102 PTHrP 102-111 RYLTQETNKV A24
SART3-511 SART3 511-519 WLEYYNLER A3supa
SART3-734 SART3 734-742 QIRPIFSNR A3supa
Lck-90 p56 lck 90-99 ILEQSGEWWK A3supa
Lck-449 p56 lck 449-458 VIQNLERGYR A3supa
PAP-248 PAP 248-257 GIHKQKEKSR A3supa
  1. aA3sup, HLA-A3 supertype (A3, A11, A31, and A33).